The US Supreme Court on Monday said an appeals court must take another look at whether victims of terror attacks in Iraq can move forward with their Anti-Terrorism Act suit against drugmakers.
Plaintiffs claim the group of drugmakers violated the ATA by financially supporting an Iraqi group that was responsible for attacks between 2005 and 2011.
The drugmakers challenged the US Court of Appeals for the D.C. Circuit’s ruling allowing the case to proceed. The Supreme Court’s order grants their petition, vacates the order, and remands it to the appeals court.
The drugmakers are 21 companies from five corporate families— ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.